phenelzine has been researched along with mdv 3100 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaur, S; Gross, ME; Liao, CP; Qian, B; Shih, JC | 1 |
| Antonarakis, ES; Chang, C; Chang, P; Huang, CP; Li, G; Lu, C; Luo, J; Meng, J; Niu, Y; Wang, K; Xu, W; Yeh, S; You, B; Zhu, Y | 1 |
2 other study(ies) available for phenelzine and mdv 3100
| Article | Year |
|---|---|
Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells.
Topics: Androgen Antagonists; Benzamides; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Clorgyline; Drug Resistance, Neoplasm; Humans; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neoplasm Grading; Nitriles; Phenelzine; Phenylthiohydantoin; Prostate; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen | 2019 |
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.
Topics: Alternative Splicing; Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Clorgyline; Drug Resistance, Neoplasm; Enzyme Stability; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Mice, SCID; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neoplastic Cells, Circulating; Nitriles; Phenelzine; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Signal Transduction; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |